Affordable Growth. Analyze the stocks which are showing good growth, decent profitability and health and are not overvalued from a fundamental perspective.
GMED gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. GMED is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. GMED is not overvalued while it is showing excellent growth. This is an interesting combination. This makes GMED very considerable for growth investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.94% | ||
ROE | 4.54% | ||
ROIC | 5.32% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 11.48% | ||
PM (TTM) | 7.39% | ||
GM | 60.59% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Altman-Z | 8.97 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 4.45 | ||
Quick Ratio | 2.72 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 18.75 | ||
Fwd PE | 14.5 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 15.2 | ||
EV/EBITDA | 13.42 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |